| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Th2 Cells | 28 | 2022 | 146 | 4.900 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 12 | 2011 | 95 | 2.980 |
Why?
|
| Dendritic Cells | 12 | 2023 | 425 | 2.790 |
Why?
|
| Asthma | 22 | 2022 | 955 | 2.440 |
Why?
|
| T-Lymphocytes | 30 | 2021 | 1195 | 2.300 |
Why?
|
| Lung | 25 | 2023 | 1170 | 2.020 |
Why?
|
| Hypersensitivity | 8 | 2019 | 154 | 1.610 |
Why?
|
| Cytokines | 21 | 2023 | 776 | 1.530 |
Why?
|
| Inducible T-Cell Co-Stimulator Protein | 12 | 2017 | 18 | 1.480 |
Why?
|
| Receptors, IgG | 4 | 2018 | 52 | 1.410 |
Why?
|
| Inflammation | 14 | 2021 | 920 | 1.350 |
Why?
|
| T-Lymphocyte Subsets | 16 | 2020 | 272 | 1.350 |
Why?
|
| Mice, Inbred C57BL | 41 | 2022 | 3092 | 1.280 |
Why?
|
| Interferon Regulatory Factors | 2 | 2022 | 67 | 1.280 |
Why?
|
| Mice | 71 | 2023 | 11352 | 1.280 |
Why?
|
| Immunity, Innate | 7 | 2021 | 409 | 1.270 |
Why?
|
| CD4-Positive T-Lymphocytes | 8 | 2013 | 425 | 1.180 |
Why?
|
| Disease Models, Animal | 24 | 2023 | 2232 | 1.170 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 5 | 2023 | 165 | 1.160 |
Why?
|
| fas Receptor | 4 | 2018 | 75 | 1.140 |
Why?
|
| Lymphocyte Activation | 21 | 2015 | 728 | 1.140 |
Why?
|
| CD28 Antigens | 12 | 2018 | 88 | 1.100 |
Why?
|
| Animals | 86 | 2023 | 26581 | 1.100 |
Why?
|
| Lymphocytes | 4 | 2021 | 464 | 1.090 |
Why?
|
| Antigens, CD | 15 | 2015 | 458 | 1.070 |
Why?
|
| Mice, Knockout | 25 | 2021 | 1924 | 1.050 |
Why?
|
| Leukosialin | 10 | 2013 | 16 | 1.040 |
Why?
|
| Signal Transduction | 21 | 2020 | 3241 | 1.030 |
Why?
|
| Eosinophils | 6 | 2021 | 194 | 0.990 |
Why?
|
| Acute Lung Injury | 3 | 2022 | 60 | 0.970 |
Why?
|
| Allergens | 6 | 2022 | 179 | 0.950 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 16 | 2015 | 102 | 0.940 |
Why?
|
| Immunologic Memory | 5 | 2022 | 152 | 0.930 |
Why?
|
| Th1 Cells | 9 | 2018 | 164 | 0.900 |
Why?
|
| Hypersensitivity, Immediate | 4 | 2019 | 62 | 0.900 |
Why?
|
| Cell Differentiation | 11 | 2021 | 1458 | 0.840 |
Why?
|
| Sialoglycoproteins | 6 | 2004 | 31 | 0.830 |
Why?
|
| Lymph Nodes | 10 | 2023 | 530 | 0.830 |
Why?
|
| Lung Diseases | 4 | 2022 | 263 | 0.800 |
Why?
|
| Eosinophilia | 4 | 2018 | 84 | 0.780 |
Why?
|
| Antigen-Presenting Cells | 9 | 2009 | 139 | 0.770 |
Why?
|
| Gene Expression Regulation | 10 | 2022 | 1920 | 0.760 |
Why?
|
| Interleukin-33 | 6 | 2021 | 24 | 0.730 |
Why?
|
| Interleukin-5 | 4 | 2021 | 36 | 0.720 |
Why?
|
| Interleukins | 4 | 2015 | 134 | 0.690 |
Why?
|
| Respiratory Hypersensitivity | 4 | 2020 | 41 | 0.680 |
Why?
|
| Lymphopenia | 1 | 2018 | 28 | 0.670 |
Why?
|
| Pulmonary Fibrosis | 5 | 2023 | 123 | 0.670 |
Why?
|
| Cytoskeletal Proteins | 4 | 2013 | 223 | 0.660 |
Why?
|
| Flow Cytometry | 10 | 2019 | 679 | 0.660 |
Why?
|
| Adoptive Transfer | 9 | 2018 | 168 | 0.660 |
Why?
|
| B7-1 Antigen | 7 | 2008 | 75 | 0.650 |
Why?
|
| Cells, Cultured | 16 | 2019 | 2818 | 0.650 |
Why?
|
| Immunoglobulin E | 9 | 2019 | 144 | 0.630 |
Why?
|
| Pneumonia | 4 | 2018 | 179 | 0.610 |
Why?
|
| Cell Movement | 9 | 2013 | 758 | 0.600 |
Why?
|
| Bronchoalveolar Lavage Fluid | 9 | 2021 | 121 | 0.590 |
Why?
|
| Agriculture | 1 | 2016 | 38 | 0.570 |
Why?
|
| Respiratory System | 3 | 2019 | 116 | 0.560 |
Why?
|
| Cell Communication | 4 | 2006 | 194 | 0.550 |
Why?
|
| Schistosoma mansoni | 6 | 2011 | 17 | 0.550 |
Why?
|
| Transcription, Genetic | 5 | 2019 | 1135 | 0.550 |
Why?
|
| Mice, Inbred BALB C | 15 | 2016 | 1047 | 0.540 |
Why?
|
| Adaptive Immunity | 3 | 2019 | 164 | 0.540 |
Why?
|
| Immunoconjugates | 5 | 2001 | 106 | 0.530 |
Why?
|
| Chemotaxis, Leukocyte | 2 | 2015 | 38 | 0.530 |
Why?
|
| Receptors, CCR7 | 2 | 2013 | 16 | 0.520 |
Why?
|
| Environmental Exposure | 2 | 2019 | 296 | 0.520 |
Why?
|
| Lung Diseases, Interstitial | 4 | 2020 | 235 | 0.500 |
Why?
|
| Lectins, C-Type | 1 | 2014 | 85 | 0.490 |
Why?
|
| Mice, Transgenic | 16 | 2021 | 1540 | 0.480 |
Why?
|
| Immune Tolerance | 5 | 2015 | 337 | 0.470 |
Why?
|
| B-Lymphocytes | 7 | 2021 | 724 | 0.470 |
Why?
|
| Monocytes | 1 | 2015 | 214 | 0.460 |
Why?
|
| Staphylococcus aureus | 4 | 2021 | 263 | 0.460 |
Why?
|
| Antigens, Differentiation | 6 | 2001 | 141 | 0.450 |
Why?
|
| Humans | 71 | 2023 | 86601 | 0.450 |
Why?
|
| Bleomycin | 4 | 2022 | 98 | 0.440 |
Why?
|
| Staphylococcal Infections | 4 | 2020 | 255 | 0.440 |
Why?
|
| Leukocytes, Mononuclear | 5 | 2023 | 196 | 0.440 |
Why?
|
| L-Selectin | 1 | 2011 | 16 | 0.400 |
Why?
|
| Microfilament Proteins | 3 | 2013 | 208 | 0.400 |
Why?
|
| Epithelial Cells | 5 | 2019 | 669 | 0.370 |
Why?
|
| Alveolitis, Extrinsic Allergic | 2 | 2021 | 34 | 0.370 |
Why?
|
| Membrane Proteins | 6 | 2013 | 1196 | 0.370 |
Why?
|
| Fas Ligand Protein | 2 | 2009 | 49 | 0.370 |
Why?
|
| Phenotype | 13 | 2022 | 2377 | 0.370 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2021 | 266 | 0.350 |
Why?
|
| Female | 34 | 2021 | 44507 | 0.340 |
Why?
|
| Leukocytes | 3 | 2023 | 202 | 0.340 |
Why?
|
| Respiratory Mucosa | 3 | 2021 | 88 | 0.330 |
Why?
|
| Myofibroblasts | 2 | 2023 | 43 | 0.330 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2021 | 93 | 0.330 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2023 | 559 | 0.310 |
Why?
|
| Bronchial Hyperreactivity | 4 | 2014 | 77 | 0.300 |
Why?
|
| Apoptosis | 6 | 2019 | 1683 | 0.300 |
Why?
|
| Proteins | 2 | 2011 | 777 | 0.300 |
Why?
|
| Sinusitis | 2 | 2005 | 210 | 0.280 |
Why?
|
| Male | 29 | 2021 | 40956 | 0.280 |
Why?
|
| GATA3 Transcription Factor | 3 | 2021 | 48 | 0.270 |
Why?
|
| Gene Expression | 10 | 2023 | 1284 | 0.270 |
Why?
|
| Autoimmune Diseases | 2 | 2006 | 241 | 0.270 |
Why?
|
| Bronchi | 3 | 2015 | 229 | 0.270 |
Why?
|
| Sepsis | 2 | 2020 | 306 | 0.270 |
Why?
|
| Neutrophils | 4 | 2021 | 307 | 0.260 |
Why?
|
| Pneumococcal Infections | 1 | 2005 | 46 | 0.260 |
Why?
|
| Shock, Septic | 2 | 2023 | 102 | 0.260 |
Why?
|
| HLA-G Antigens | 2 | 2017 | 52 | 0.260 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2013 | 376 | 0.260 |
Why?
|
| Immunity, Cellular | 4 | 2013 | 177 | 0.260 |
Why?
|
| Receptors, Antigen, T-Cell | 6 | 2013 | 372 | 0.250 |
Why?
|
| Lymphocyte Subsets | 2 | 2015 | 64 | 0.250 |
Why?
|
| Promoter Regions, Genetic | 2 | 2021 | 937 | 0.250 |
Why?
|
| Influenza, Human | 2 | 2021 | 329 | 0.240 |
Why?
|
| Bacteremia | 3 | 2020 | 99 | 0.240 |
Why?
|
| Antibodies | 2 | 2018 | 350 | 0.240 |
Why?
|
| HLA-A2 Antigen | 1 | 2023 | 31 | 0.240 |
Why?
|
| Interleukin-2 | 9 | 2018 | 249 | 0.240 |
Why?
|
| Pulmonary Edema | 2 | 2021 | 50 | 0.240 |
Why?
|
| Inducible T-Cell Co-Stimulator Ligand | 3 | 2011 | 3 | 0.240 |
Why?
|
| Extracellular Traps | 1 | 2022 | 11 | 0.230 |
Why?
|
| Lung Transplantation | 3 | 2020 | 175 | 0.220 |
Why?
|
| Up-Regulation | 5 | 2020 | 712 | 0.220 |
Why?
|
| Amish | 2 | 2019 | 6 | 0.220 |
Why?
|
| Probiotics | 1 | 2023 | 81 | 0.220 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2021 | 2356 | 0.210 |
Why?
|
| Mediastinum | 2 | 2019 | 46 | 0.210 |
Why?
|
| Microbiota | 2 | 2019 | 381 | 0.210 |
Why?
|
| Epigenesis, Genetic | 2 | 2016 | 479 | 0.210 |
Why?
|
| Interleukin-13 | 3 | 2019 | 36 | 0.210 |
Why?
|
| CD3 Complex | 4 | 2018 | 135 | 0.210 |
Why?
|
| Immunity | 2 | 2020 | 136 | 0.210 |
Why?
|
| Bone Marrow Cells | 2 | 2013 | 253 | 0.210 |
Why?
|
| Interleukin-10 | 3 | 2013 | 149 | 0.210 |
Why?
|
| Cell Membrane | 2 | 2009 | 666 | 0.210 |
Why?
|
| DNA Methylation | 2 | 2016 | 628 | 0.200 |
Why?
|
| Respiratory Tract Infections | 1 | 2022 | 105 | 0.200 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2021 | 5 | 0.200 |
Why?
|
| Isoenzymes | 2 | 2013 | 271 | 0.200 |
Why?
|
| Interleukin-4 | 3 | 2011 | 127 | 0.200 |
Why?
|
| Disease Susceptibility | 2 | 2020 | 193 | 0.200 |
Why?
|
| Th17 Cells | 3 | 2019 | 80 | 0.200 |
Why?
|
| Protein Kinase C | 2 | 2013 | 270 | 0.200 |
Why?
|
| Graft vs Host Disease | 1 | 2023 | 365 | 0.200 |
Why?
|
| Palatine Tonsil | 1 | 2021 | 30 | 0.200 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2020 | 18 | 0.190 |
Why?
|
| Thioredoxins | 1 | 2020 | 13 | 0.190 |
Why?
|
| Thymus Gland | 5 | 2010 | 195 | 0.190 |
Why?
|
| Academic Medical Centers | 1 | 2023 | 379 | 0.190 |
Why?
|
| Colitis | 1 | 2023 | 239 | 0.190 |
Why?
|
| Leukocyte Count | 2 | 2021 | 220 | 0.190 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2020 | 24 | 0.190 |
Why?
|
| Body Temperature | 1 | 2020 | 124 | 0.190 |
Why?
|
| Adjuvants, Immunologic | 4 | 2021 | 167 | 0.190 |
Why?
|
| Nanofibers | 1 | 2020 | 31 | 0.190 |
Why?
|
| Lymphangiogenesis | 1 | 2020 | 38 | 0.180 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2020 | 87 | 0.180 |
Why?
|
| Pyridones | 1 | 2020 | 51 | 0.180 |
Why?
|
| Transcriptome | 3 | 2019 | 580 | 0.180 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2019 | 10 | 0.180 |
Why?
|
| Influenza Vaccines | 1 | 2021 | 142 | 0.180 |
Why?
|
| Immunophenotyping | 6 | 2020 | 211 | 0.180 |
Why?
|
| Thrombosis | 1 | 2022 | 296 | 0.180 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2019 | 15 | 0.180 |
Why?
|
| Cell Adhesion Molecules | 1 | 2000 | 163 | 0.170 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2015 | 263 | 0.170 |
Why?
|
| Fungi | 1 | 2019 | 65 | 0.170 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 4 | 1997 | 100 | 0.170 |
Why?
|
| Indoles | 1 | 2020 | 318 | 0.160 |
Why?
|
| Biomarkers | 6 | 2020 | 1718 | 0.160 |
Why?
|
| Lymphoid Tissue | 2 | 2021 | 57 | 0.160 |
Why?
|
| Antigens, Helminth | 3 | 2011 | 22 | 0.160 |
Why?
|
| Immunosuppressive Agents | 3 | 2001 | 977 | 0.160 |
Why?
|
| Lymphocyte Count | 3 | 2018 | 94 | 0.160 |
Why?
|
| Antigen Presentation | 5 | 2007 | 209 | 0.160 |
Why?
|
| Farms | 1 | 2017 | 5 | 0.160 |
Why?
|
| Interleukin-6 | 1 | 2019 | 256 | 0.160 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 217 | 0.160 |
Why?
|
| Population | 1 | 2017 | 35 | 0.150 |
Why?
|
| Chromosome Mapping | 3 | 2016 | 1074 | 0.150 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2001 | 645 | 0.150 |
Why?
|
| Child | 5 | 2023 | 6926 | 0.150 |
Why?
|
| Stem Cells | 1 | 2019 | 351 | 0.150 |
Why?
|
| Christianity | 1 | 2016 | 36 | 0.140 |
Why?
|
| Disease Progression | 5 | 2020 | 1531 | 0.140 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2016 | 49 | 0.140 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2016 | 47 | 0.140 |
Why?
|
| Dust | 1 | 2016 | 26 | 0.140 |
Why?
|
| Abatacept | 5 | 2001 | 83 | 0.140 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 1673 | 0.140 |
Why?
|
| Immunotherapy | 1 | 2001 | 629 | 0.140 |
Why?
|
| Ovalbumin | 4 | 2015 | 109 | 0.140 |
Why?
|
| RGS Proteins | 2 | 2013 | 19 | 0.140 |
Why?
|
| CTLA-4 Antigen | 5 | 2001 | 135 | 0.140 |
Why?
|
| Time Factors | 6 | 2015 | 5209 | 0.140 |
Why?
|
| Prevalence | 2 | 2017 | 1239 | 0.140 |
Why?
|
| Physicians | 1 | 2023 | 673 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 1996 | 189 | 0.130 |
Why?
|
| Antibodies, Monoclonal | 5 | 2002 | 1376 | 0.130 |
Why?
|
| Genome-Wide Association Study | 3 | 2022 | 1620 | 0.130 |
Why?
|
| Calcitriol | 1 | 2016 | 174 | 0.130 |
Why?
|
| Adult | 13 | 2023 | 25640 | 0.130 |
Why?
|
| Bacterial Translocation | 1 | 2015 | 26 | 0.130 |
Why?
|
| Salmonella Infections, Animal | 1 | 2015 | 11 | 0.130 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2007 | 316 | 0.130 |
Why?
|
| Models, Animal | 1 | 2016 | 263 | 0.130 |
Why?
|
| Toxoplasmosis, Animal | 1 | 2015 | 20 | 0.130 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2023 | 88 | 0.130 |
Why?
|
| Protein Kinase C-theta | 2 | 2013 | 16 | 0.130 |
Why?
|
| Salmonella typhimurium | 1 | 2015 | 32 | 0.130 |
Why?
|
| Pandemics | 1 | 2021 | 740 | 0.130 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2014 | 11 | 0.130 |
Why?
|
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2014 | 12 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2011 | 557 | 0.130 |
Why?
|
| Receptors, Interleukin | 1 | 2014 | 35 | 0.120 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2022 | 241 | 0.120 |
Why?
|
| Inflammation Mediators | 2 | 2018 | 154 | 0.120 |
Why?
|
| Alleles | 3 | 2021 | 1127 | 0.120 |
Why?
|
| Dermatitis, Atopic | 1 | 2015 | 52 | 0.120 |
Why?
|
| Polymorphism, Genetic | 1 | 2018 | 819 | 0.120 |
Why?
|
| GATA5 Transcription Factor | 1 | 2014 | 7 | 0.120 |
Why?
|
| Antigen-Antibody Complex | 1 | 2014 | 87 | 0.120 |
Why?
|
| Specific Pathogen-Free Organisms | 2 | 2009 | 74 | 0.120 |
Why?
|
| Middle Aged | 12 | 2020 | 25017 | 0.120 |
Why?
|
| Bronchoconstriction | 1 | 2014 | 55 | 0.120 |
Why?
|
| Cell Proliferation | 4 | 2016 | 1578 | 0.120 |
Why?
|
| Proportional Hazards Models | 3 | 2023 | 857 | 0.120 |
Why?
|
| Interferon-gamma | 3 | 2018 | 444 | 0.120 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2014 | 124 | 0.120 |
Why?
|
| Adrenomedullin | 1 | 2013 | 5 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2021 | 2270 | 0.120 |
Why?
|
| DNA | 2 | 2022 | 1294 | 0.120 |
Why?
|
| Graft Rejection | 3 | 2013 | 1065 | 0.120 |
Why?
|
| Macrophages | 2 | 2014 | 554 | 0.110 |
Why?
|
| Intestinal Mucosa | 3 | 2015 | 797 | 0.110 |
Why?
|
| Lung Injury | 1 | 2013 | 47 | 0.110 |
Why?
|
| Mites | 1 | 2013 | 16 | 0.110 |
Why?
|
| Cell Survival | 2 | 2011 | 969 | 0.110 |
Why?
|
| Aged | 9 | 2021 | 18402 | 0.110 |
Why?
|
| Sarcoidosis | 1 | 2013 | 71 | 0.110 |
Why?
|
| Immunoglobulin G | 2 | 2013 | 456 | 0.110 |
Why?
|
| Fluorescent Dyes | 1 | 2013 | 242 | 0.110 |
Why?
|
| Sarcoidosis, Pulmonary | 1 | 2012 | 17 | 0.110 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2012 | 29 | 0.110 |
Why?
|
| Intercellular Junctions | 2 | 2002 | 68 | 0.110 |
Why?
|
| Acute Disease | 3 | 2017 | 826 | 0.110 |
Why?
|
| Homozygote | 2 | 2018 | 200 | 0.100 |
Why?
|
| Ligands | 3 | 2000 | 433 | 0.100 |
Why?
|
| Adolescent | 4 | 2019 | 8979 | 0.100 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2013 | 166 | 0.100 |
Why?
|
| Down-Regulation | 2 | 2011 | 504 | 0.100 |
Why?
|
| Phospholipases A | 2 | 2002 | 45 | 0.100 |
Why?
|
| Immunological Synapses | 1 | 2011 | 5 | 0.100 |
Why?
|
| Autopsy | 2 | 2021 | 116 | 0.100 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 1621 | 0.100 |
Why?
|
| Cytoprotection | 1 | 2011 | 47 | 0.100 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2011 | 46 | 0.100 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2010 | 31 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 689 | 0.090 |
Why?
|
| Mice, Inbred C3H | 2 | 2009 | 370 | 0.090 |
Why?
|
| Molecular Sequence Data | 7 | 2007 | 3030 | 0.090 |
Why?
|
| Influenza A virus | 1 | 2011 | 169 | 0.090 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2009 | 14 | 0.090 |
Why?
|
| Transplantation, Homologous | 2 | 2023 | 996 | 0.090 |
Why?
|
| Transcription Factors | 2 | 2014 | 1565 | 0.090 |
Why?
|
| Histocytochemistry | 1 | 2009 | 130 | 0.090 |
Why?
|
| Lysophospholipids | 1 | 2009 | 63 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2016 | 1351 | 0.090 |
Why?
|
| Reperfusion Injury | 1 | 2010 | 131 | 0.090 |
Why?
|
| Protein Binding | 3 | 2022 | 1456 | 0.080 |
Why?
|
| Amino Acid Sequence | 4 | 2007 | 2062 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 2600 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2007 | 416 | 0.080 |
Why?
|
| United States | 4 | 2023 | 6665 | 0.080 |
Why?
|
| Cohort Studies | 3 | 2020 | 2767 | 0.080 |
Why?
|
| Antigens | 3 | 2013 | 228 | 0.080 |
Why?
|
| Smad Proteins | 1 | 2008 | 39 | 0.080 |
Why?
|
| Mice, Mutant Strains | 4 | 2008 | 229 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2013 | 534 | 0.080 |
Why?
|
| Lymphoma, B-Cell | 1 | 1989 | 103 | 0.080 |
Why?
|
| Promyelocytic Leukemia Zinc Finger Protein | 2 | 2019 | 15 | 0.080 |
Why?
|
| Pyroglyphidae | 2 | 2020 | 14 | 0.080 |
Why?
|
| GTP-Binding Proteins | 1 | 2008 | 146 | 0.080 |
Why?
|
| GTPase-Activating Proteins | 1 | 2008 | 65 | 0.080 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2018 | 295 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2007 | 268 | 0.080 |
Why?
|
| Transduction, Genetic | 1 | 2007 | 153 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2007 | 103 | 0.070 |
Why?
|
| Myeloid Cells | 2 | 2019 | 98 | 0.070 |
Why?
|
| Airway Obstruction | 1 | 2008 | 109 | 0.070 |
Why?
|
| Conserved Sequence | 1 | 2007 | 210 | 0.070 |
Why?
|
| Binding Sites | 2 | 2008 | 1098 | 0.070 |
Why?
|
| Genotype | 3 | 2018 | 1850 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 623 | 0.070 |
Why?
|
| Environment | 1 | 2008 | 219 | 0.070 |
Why?
|
| In Vitro Techniques | 3 | 2021 | 989 | 0.070 |
Why?
|
| Genes, RAG-1 | 1 | 2005 | 13 | 0.070 |
Why?
|
| Homeodomain Proteins | 1 | 2009 | 536 | 0.070 |
Why?
|
| Receptors, IgE | 2 | 1996 | 7 | 0.070 |
Why?
|
| 5' Untranslated Regions | 1 | 2005 | 49 | 0.070 |
Why?
|
| Streptococcus pneumoniae | 1 | 2005 | 48 | 0.070 |
Why?
|
| Membrane Glycoproteins | 2 | 1998 | 428 | 0.070 |
Why?
|
| Gene Regulatory Networks | 1 | 2008 | 296 | 0.070 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2003 | 89 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2007 | 1106 | 0.060 |
Why?
|
| Bone Marrow Transplantation | 2 | 2015 | 286 | 0.060 |
Why?
|
| Bronchoalveolar Lavage | 2 | 2021 | 26 | 0.060 |
Why?
|
| Epitopes | 2 | 2022 | 255 | 0.060 |
Why?
|
| Mice, Inbred DBA | 5 | 1997 | 148 | 0.060 |
Why?
|
| Lymphotoxin-alpha | 1 | 2003 | 44 | 0.060 |
Why?
|
| Young Adult | 4 | 2019 | 5974 | 0.060 |
Why?
|
| Occludin | 2 | 2015 | 66 | 0.060 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2003 | 57 | 0.060 |
Why?
|
| Cross-Priming | 1 | 2023 | 48 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2023 | 4210 | 0.060 |
Why?
|
| HIV Infections | 1 | 2012 | 772 | 0.060 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2013 | 158 | 0.060 |
Why?
|
| Bacillus subtilis | 1 | 2023 | 89 | 0.060 |
Why?
|
| Models, Immunological | 3 | 2002 | 80 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 2705 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 3 | 2014 | 1041 | 0.060 |
Why?
|
| Personnel Selection | 1 | 2023 | 59 | 0.060 |
Why?
|
| Viral Envelope Proteins | 2 | 1994 | 94 | 0.060 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2022 | 32 | 0.060 |
Why?
|
| Bacterial Infections | 1 | 2004 | 182 | 0.050 |
Why?
|
| Antigens, Surface | 2 | 2015 | 101 | 0.050 |
Why?
|
| Quantitative Trait Loci | 2 | 2016 | 576 | 0.050 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2022 | 40 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2006 | 970 | 0.050 |
Why?
|
| Angiotensin II | 1 | 2022 | 94 | 0.050 |
Why?
|
| Cricetinae | 3 | 2008 | 560 | 0.050 |
Why?
|
| Goblet Cells | 2 | 2014 | 19 | 0.050 |
Why?
|
| Telomere | 1 | 2023 | 108 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 1384 | 0.050 |
Why?
|
| Japan | 1 | 2022 | 307 | 0.050 |
Why?
|
| Simplexvirus | 2 | 1994 | 151 | 0.050 |
Why?
|
| Thorax | 1 | 2022 | 75 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 2 | 2013 | 236 | 0.050 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 2021 | 17 | 0.050 |
Why?
|
| Strongyloidiasis | 1 | 2021 | 5 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2013 | 1208 | 0.050 |
Why?
|
| Leadership | 1 | 2023 | 134 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-maf | 1 | 2001 | 4 | 0.050 |
Why?
|
| Particulate Matter | 1 | 2022 | 79 | 0.050 |
Why?
|
| Leukocyte Reduction Procedures | 1 | 2021 | 3 | 0.050 |
Why?
|
| Diphtheria Toxin | 1 | 2021 | 20 | 0.050 |
Why?
|
| Autoantibodies | 1 | 2022 | 267 | 0.050 |
Why?
|
| CD40 Ligand | 1 | 2001 | 69 | 0.050 |
Why?
|
| Faculty, Medical | 1 | 2023 | 178 | 0.050 |
Why?
|
| Dexamethasone | 1 | 2003 | 326 | 0.050 |
Why?
|
| Rabies Vaccines | 1 | 2021 | 7 | 0.050 |
Why?
|
| Measles-Mumps-Rubella Vaccine | 1 | 2021 | 7 | 0.050 |
Why?
|
| Weight Loss | 1 | 2022 | 229 | 0.050 |
Why?
|
| Macromolecular Substances | 2 | 1998 | 177 | 0.050 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2021 | 70 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2023 | 339 | 0.050 |
Why?
|
| In Situ Hybridization | 1 | 2021 | 307 | 0.050 |
Why?
|
| CD8 Antigens | 2 | 1992 | 82 | 0.050 |
Why?
|
| Germinal Center | 1 | 2021 | 55 | 0.050 |
Why?
|
| CD4 Antigens | 2 | 1992 | 83 | 0.050 |
Why?
|
| Mice, Inbred NOD | 2 | 2013 | 187 | 0.050 |
Why?
|
| Organoids | 1 | 2021 | 61 | 0.050 |
Why?
|
| CD11 Antigens | 1 | 2000 | 14 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2020 | 26 | 0.050 |
Why?
|
| Vaccines, Subunit | 1 | 2020 | 55 | 0.050 |
Why?
|
| Fibrosis | 1 | 2021 | 203 | 0.050 |
Why?
|
| Leukotriene C4 | 1 | 2000 | 21 | 0.050 |
Why?
|
| Protein Stability | 1 | 2020 | 99 | 0.050 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2000 | 39 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2016 | 1804 | 0.050 |
Why?
|
| Chitinase-3-Like Protein 1 | 1 | 2020 | 9 | 0.050 |
Why?
|
| CD18 Antigens | 1 | 2000 | 22 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2022 | 1801 | 0.050 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2020 | 11 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 227 | 0.050 |
Why?
|
| CA-125 Antigen | 1 | 2020 | 22 | 0.050 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2000 | 71 | 0.050 |
Why?
|
| Chemokine CXCL13 | 1 | 2020 | 15 | 0.050 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 1 | 2020 | 7 | 0.050 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2020 | 83 | 0.050 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2020 | 56 | 0.050 |
Why?
|
| Gene Ontology | 1 | 2019 | 34 | 0.050 |
Why?
|
| V(D)J Recombination | 1 | 2019 | 10 | 0.050 |
Why?
|
| Blotting, Western | 3 | 2013 | 782 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2023 | 729 | 0.050 |
Why?
|
| Fever | 1 | 2020 | 125 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2001 | 439 | 0.050 |
Why?
|
| Seasons | 1 | 2021 | 223 | 0.040 |
Why?
|
| Vital Capacity | 1 | 2020 | 64 | 0.040 |
Why?
|
| Cellular Reprogramming | 1 | 2019 | 37 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2005 | 2426 | 0.040 |
Why?
|
| Clone Cells | 2 | 1997 | 213 | 0.040 |
Why?
|
| Homeostasis | 1 | 2021 | 409 | 0.040 |
Why?
|
| Trachea | 1 | 2000 | 293 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2020 | 329 | 0.040 |
Why?
|
| Connective Tissue Diseases | 1 | 2020 | 67 | 0.040 |
Why?
|
| Antigens, CD1d | 1 | 2019 | 29 | 0.040 |
Why?
|
| Cell Separation | 1 | 2019 | 196 | 0.040 |
Why?
|
| Leukocyte Common Antigens | 1 | 1998 | 46 | 0.040 |
Why?
|
| Zebrafish | 1 | 2021 | 309 | 0.040 |
Why?
|
| Comorbidity | 1 | 2022 | 943 | 0.040 |
Why?
|
| Chromatin | 1 | 2021 | 380 | 0.040 |
Why?
|
| Spleen | 4 | 2010 | 430 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2000 | 420 | 0.040 |
Why?
|
| Congresses as Topic | 1 | 2019 | 116 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 2 | 2013 | 301 | 0.040 |
Why?
|
| Motion | 1 | 1998 | 85 | 0.040 |
Why?
|
| Protein Folding | 1 | 2020 | 280 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2001 | 429 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1999 | 302 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 1999 | 267 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 1999 | 302 | 0.040 |
Why?
|
| Interleukin-12 | 1 | 2018 | 108 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 307 | 0.040 |
Why?
|
| Actins | 2 | 2013 | 451 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2021 | 1538 | 0.040 |
Why?
|
| Heterozygote | 1 | 2018 | 365 | 0.040 |
Why?
|
| Glycoproteins | 2 | 2003 | 234 | 0.040 |
Why?
|
| Immunoglobulin Variable Region | 1 | 1997 | 109 | 0.040 |
Why?
|
| Minor Lymphocyte Stimulatory Antigens | 2 | 1996 | 3 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2022 | 1143 | 0.040 |
Why?
|
| bcl-X Protein | 1 | 1996 | 52 | 0.040 |
Why?
|
| Arthritis | 2 | 1994 | 46 | 0.040 |
Why?
|
| B7-2 Antigen | 1 | 1996 | 40 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2021 | 1753 | 0.040 |
Why?
|
| Rural Population | 1 | 2017 | 136 | 0.040 |
Why?
|
| Europe | 1 | 2017 | 309 | 0.040 |
Why?
|
| Mice, Inbred Strains | 4 | 2000 | 307 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 1999 | 673 | 0.030 |
Why?
|
| Helminths | 1 | 2015 | 3 | 0.030 |
Why?
|
| Mutation | 1 | 2007 | 3967 | 0.030 |
Why?
|
| Helminthiasis | 1 | 2015 | 3 | 0.030 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2015 | 4 | 0.030 |
Why?
|
| Survival Rate | 1 | 2020 | 1860 | 0.030 |
Why?
|
| Papain | 1 | 2015 | 6 | 0.030 |
Why?
|
| Liver Diseases, Parasitic | 1 | 1995 | 1 | 0.030 |
Why?
|
| Heart Transplantation | 1 | 2001 | 705 | 0.030 |
Why?
|
| Schistosomiasis mansoni | 1 | 1995 | 9 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2016 | 148 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2017 | 278 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2019 | 572 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2015 | 122 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 6501 | 0.030 |
Why?
|
| Collagen | 2 | 1994 | 269 | 0.030 |
Why?
|
| RNA, Bacterial | 1 | 2015 | 108 | 0.030 |
Why?
|
| Receptors, Calcitriol | 1 | 2016 | 129 | 0.030 |
Why?
|
| Integrin alpha Chains | 1 | 2015 | 15 | 0.030 |
Why?
|
| Granuloma | 1 | 1995 | 65 | 0.030 |
Why?
|
| Cell Division | 1 | 1996 | 696 | 0.030 |
Why?
|
| HLA-D Antigens | 1 | 1995 | 20 | 0.030 |
Why?
|
| Permeability | 1 | 2015 | 137 | 0.030 |
Why?
|
| Lymphokines | 1 | 1995 | 76 | 0.030 |
Why?
|
| Transplantation Chimera | 1 | 2015 | 80 | 0.030 |
Why?
|
| Major Histocompatibility Complex | 1 | 1995 | 81 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 683 | 0.030 |
Why?
|
| Recombinant Proteins | 3 | 2002 | 1014 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2014 | 164 | 0.030 |
Why?
|
| Metaplasia | 1 | 2014 | 37 | 0.030 |
Why?
|
| Virulence | 1 | 2015 | 271 | 0.030 |
Why?
|
| Microtubule-Organizing Center | 1 | 2013 | 5 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 1995 | 347 | 0.030 |
Why?
|
| Methacholine Chloride | 2 | 2008 | 64 | 0.030 |
Why?
|
| Mice, Inbred CBA | 2 | 1995 | 52 | 0.030 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2013 | 85 | 0.030 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 1994 | 113 | 0.030 |
Why?
|
| Heat-Shock Proteins | 1 | 1995 | 179 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1995 | 203 | 0.030 |
Why?
|
| Thy-1 Antigens | 2 | 1994 | 16 | 0.030 |
Why?
|
| Receptor Activity-Modifying Protein 2 | 1 | 2013 | 2 | 0.030 |
Why?
|
| Calcitonin Receptor-Like Protein | 1 | 2013 | 3 | 0.030 |
Why?
|
| Iloprost | 1 | 2013 | 15 | 0.030 |
Why?
|
| Chicago | 1 | 2018 | 1379 | 0.030 |
Why?
|
| Glucose-6-Phosphate Isomerase | 1 | 2013 | 8 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2014 | 129 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2014 | 132 | 0.030 |
Why?
|
| Oligonucleotides | 1 | 2013 | 92 | 0.030 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2014 | 170 | 0.030 |
Why?
|
| Cricetulus | 2 | 2008 | 126 | 0.030 |
Why?
|
| Maternal Exposure | 1 | 2013 | 57 | 0.030 |
Why?
|
| Genes, MHC Class I | 1 | 1992 | 48 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2013 | 107 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2015 | 231 | 0.030 |
Why?
|
| CHO Cells | 2 | 2008 | 187 | 0.030 |
Why?
|
| Transfection | 2 | 2008 | 896 | 0.030 |
Why?
|
| Demography | 1 | 2013 | 177 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2013 | 273 | 0.030 |
Why?
|
| Autoantigens | 1 | 2013 | 127 | 0.030 |
Why?
|
| Vaccines, DNA | 1 | 2012 | 16 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1034 | 0.030 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2012 | 70 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 3674 | 0.030 |
Why?
|
| Bacteria | 1 | 2015 | 447 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2012 | 213 | 0.030 |
Why?
|
| Group V Phospholipases A2 | 2 | 2002 | 9 | 0.030 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 1991 | 20 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 305 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2014 | 418 | 0.020 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2012 | 132 | 0.020 |
Why?
|
| HIV-1 | 1 | 2012 | 163 | 0.020 |
Why?
|
| Species Specificity | 1 | 1992 | 678 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2012 | 254 | 0.020 |
Why?
|
| T-Box Domain Proteins | 1 | 2012 | 118 | 0.020 |
Why?
|
| Haplotypes | 1 | 1992 | 642 | 0.020 |
Why?
|
| Cell Count | 1 | 2010 | 195 | 0.020 |
Why?
|
| Egg Proteins | 1 | 2009 | 10 | 0.020 |
Why?
|
| Liver | 1 | 1995 | 1229 | 0.020 |
Why?
|
| Radiography | 1 | 2012 | 813 | 0.020 |
Why?
|
| Antigens, Protozoan | 1 | 2009 | 21 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2009 | 69 | 0.020 |
Why?
|
| Base Sequence | 4 | 1995 | 2330 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2010 | 143 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2009 | 100 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2010 | 163 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2008 | 1961 | 0.020 |
Why?
|
| Antigens, Ly | 1 | 1989 | 37 | 0.020 |
Why?
|
| Transplantation Tolerance | 1 | 2010 | 130 | 0.020 |
Why?
|
| Smad3 Protein | 1 | 2008 | 15 | 0.020 |
Why?
|
| Smad2 Protein | 1 | 2008 | 17 | 0.020 |
Why?
|
| Smad4 Protein | 1 | 2008 | 23 | 0.020 |
Why?
|
| Plethysmography | 1 | 2008 | 18 | 0.020 |
Why?
|
| Bronchial Provocation Tests | 1 | 2008 | 24 | 0.020 |
Why?
|
| ROC Curve | 1 | 2010 | 752 | 0.020 |
Why?
|
| Blood Cell Count | 1 | 2008 | 79 | 0.020 |
Why?
|
| Aerosols | 1 | 2008 | 44 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2008 | 134 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2008 | 199 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2008 | 393 | 0.020 |
Why?
|
| Cell Line | 3 | 1999 | 2468 | 0.020 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2010 | 247 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2008 | 160 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 5416 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 736 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2008 | 579 | 0.020 |
Why?
|
| Pedigree | 1 | 2008 | 966 | 0.020 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2003 | 9 | 0.020 |
Why?
|
| H-2 Antigens | 2 | 1996 | 58 | 0.010 |
Why?
|
| Calcium | 1 | 2008 | 1156 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2003 | 252 | 0.010 |
Why?
|
| Aging | 1 | 2008 | 691 | 0.010 |
Why?
|
| Respiratory Mechanics | 1 | 2003 | 102 | 0.010 |
Why?
|
| Neurofibromin 2 | 1 | 2002 | 30 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2002 | 290 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2003 | 460 | 0.010 |
Why?
|
| TNF Receptor-Associated Factor 4 | 1 | 2000 | 1 | 0.010 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2000 | 5 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 1998 | 1981 | 0.010 |
Why?
|
| Phospholipases A2 | 1 | 2000 | 44 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2000 | 72 | 0.010 |
Why?
|
| Hybridomas | 1 | 2000 | 74 | 0.010 |
Why?
|
| Larynx | 1 | 2000 | 38 | 0.010 |
Why?
|
| Cross Reactions | 1 | 2000 | 106 | 0.010 |
Why?
|
| Respiration Disorders | 1 | 2000 | 39 | 0.010 |
Why?
|
| Muridae | 1 | 1999 | 8 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1999 | 171 | 0.010 |
Why?
|
| Gene Library | 1 | 1999 | 130 | 0.010 |
Why?
|
| Lymphoma, T-Cell | 1 | 1999 | 48 | 0.010 |
Why?
|
| Incidence | 1 | 2003 | 1576 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2000 | 270 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2002 | 597 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1999 | 351 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1999 | 646 | 0.010 |
Why?
|
| Bronchoconstrictor Agents | 1 | 1998 | 12 | 0.010 |
Why?
|
| Antibodies, Helminth | 1 | 1998 | 11 | 0.010 |
Why?
|
| Airway Resistance | 1 | 1998 | 69 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1998 | 104 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 1990 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1998 | 879 | 0.010 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1996 | 47 | 0.010 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1995 | 11 | 0.010 |
Why?
|
| beta 2-Microglobulin | 1 | 1995 | 24 | 0.010 |
Why?
|
| Schistosomiasis | 1 | 1994 | 5 | 0.010 |
Why?
|
| Synovial Membrane | 1 | 1993 | 28 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1993 | 268 | 0.010 |
Why?
|
| Listeriosis | 1 | 1994 | 84 | 0.010 |
Why?
|
| Cyclosporine | 1 | 1994 | 234 | 0.010 |
Why?
|
| Epithelium | 1 | 1993 | 319 | 0.010 |
Why?
|
| Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1991 | 14 | 0.010 |
Why?
|
| Intestines | 1 | 1993 | 411 | 0.010 |
Why?
|
| Herpes Simplex | 1 | 1992 | 202 | 0.010 |
Why?
|
| Mice, Nude | 1 | 1991 | 790 | 0.010 |
Why?
|